Ismail A Walbi

Najran University - Najran / Saudi Arabia

Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

AD Scientific Index ID: 5287896

Arabic

Registration, Add Profile,
Premium Membership

Print Your Certificate

Ismail A Walbi's MOST POPULAR ARTICLES

1-) A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia I Gojo, JH Beumer, KW Pratz, MA McDevitt, MR Baer, AL Blackford, ... Clinical Cancer Research 23 (3), 697-706, 2017 692017

2-) Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti … S Voruganti, JJ Qin, S Sarkar, S Nag, IA Walbi, S Wang, Y Zhao, W Wang, ... Oncotarget 6 (25), 21379, 2015 652015

3-) Roflumilast protects from cisplatin-induced testicular toxicity in male rats and enhances its cytotoxicity in prostate cancer cell line. Role of NF-κB-p65, cAMP/PKA and Nrf2/HO … BA Abdel-Wahab, IA Walbi, HA Albarqi, FEM Ali, EHM Hassanein Food and Chemical Toxicology 151, 112133, 2021 312021

4-) Development of a curcumin-loaded lecithin/chitosan nanoparticle utilizing a box-behnken design of experiment: formulation design and influence of process parametersIA Walbi, MZ Ahmad, J Ahmad, MS Algahtani, AS Alali, SA Alsudir, ...Polymers 14 (18), 3758, 2022262022

5-) Microwave enabled physically cross linked sodium alginate and pectin film and their application in combination with modified chitosan-curcumin nanoparticles. A novel strategy …HM Basit, M Ali, MM Shah, SU Shah, A Wahab, HA Albarqi, AA Alqahtani, ...Polymers 13 (16), 2716, 2021212021

ARTICLES

Add your articles